NOVEL TREATMENT APPROACHES IN REACTIVE ARTHRITIS: CLINICAL AND CYTOKINE RESPONSES TO IGURATIMOD 25 MG COMPARED WITH BIOLOGIC AND CONVENTIONAL THERAPIES. JUSR. 2025;1(Maxsus son (FARMAKOLOGIYA, FARMATSEVTIKA):86-86. Accessed May 18, 2026. https://universalpublishings.com/~niverta1/index.php/jusr/article/view/14971